Immune response that protects against infections also drives HIV latency

An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, researchers at Duke Health report.

Renaissance of “food as medicine” in modern clinical trials

Priya Venkatesan discusses in Nature Medicine how dietary interventions can prevent or delay diseases, highlighting the reemergence of “food as medicine” in modern clinical trials.

April 17, 2024

Updated: Novartis close to acquiring Cytokinetics after biotech’s PhIII heart disease win — WSJ

Novartis is in discussions to buy Cytokinetics, the Wall Street Journal reported Monday, sending the biotech’s stock $CYTK soaring nearly 15%. The deal could be

January 9, 2024

Ohio State study reveals bacterial defense mechanism against phages

One of the many secrets to bacteria’s success is their ability to defend themselves from viruses, called phages, that infect bacteria and use their cellular

April 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.